Innovation Digest – July 2019 Vol. 2

We need solutions. We also need to ensure that those solutions represent the interests of the most vulnerable in the health care equation. Of course, the cost of care and health technology is out of hand and we need to demand and pay for what works. We also need to ensure that the methods used to evaluate benefit clearly accommodate and build our understanding of patient sub-groups and outcomes that matter to patients and address comparative value across medical interventions. Even more important, we need a simultaneous commitment to evaluating the impact of these policies. They may save us a buck now, but do they cost us more in lost health and unnecessary care due to delayed or sub-optimal treatment? We don’t know. And it should raise concern that we don’t have a plan for finding the answer.

In this issue:

  • Sound, Fury and Prescription Drugs
  • In the Drive to Decrease Low-Value Care, Many Don’t Assess Whether They’re Doing the Right Thing for the Right Patient
  • In a small study, a cancer vaccine assist beats immunotherapy drugs alone
  • Streamlining Patient-Reported Outcomes to Boost Value-Based Care
  • Digital health is growing fast — but at what cost?
  • It’s time to change the definition of ‘health’
Back to Viewpoint